Inhaled Treprostinil in Pulmonary Hypertension Associated with Lung Disease.
Mariana Faria-UrbinaRudolf K F OliveiraManyoo AgarwalAaron B WaxmanPublished in: Lung (2017)
The results suggest that iTre is safe in patients with Group 3 PH and evidence of pulmonary vascular remodeling in terms of functional class, gas exchange, and exercise capacity. Additionally, iTre was well tolerated. The potential role of PH-specific drugs in Group 3 PH should be further assessed in larger prospective studies.